Poland· PL-100407900
Rosuvastatin + Acetylsalicylic acid Rafarm
A rosuvastatin und acetylsalicylsäure product containing rosuvastatinum + acidum acetylsalicylicum, registered in Poland by RAFARM S.A.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rosuvastatin und acetylsalicylsäure is registered in 2 of 19 countries.
Countries holding a registration under ATC C10BX05 (rosuvastatin und acetylsalicylsäure), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Rosuvastatin und acetylsalicylsäure · ATC C10BX05
2 / 19 countries
- Italyprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Rosuvastatinum + Acidum acetylsalicylicum
- Manufacturer
- RAFARM S.A.
- Country
- Poland (PL)
- ATC code
- C10BX05
- ATC class
- Rosuvastatin und Acetylsalicylsäure
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991451578
- gtin05909991451585
- gtin05909991451592
- gtin05909991451608
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rosuvastatin und acetylsalicylsäure in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyLUGAREXIANEOPHARMED GENTILI S.P.A.
- SpainASPIFOX 10 MG/100 MG CAPSULAS DURASTeva B.V.
- GermanyRosuassApontis Pharma Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Rosuass
- Bulgaria · Розувастатин/Ацетилсалицилова Киселина Адамед, Росстааси
- Cyprus · Rosu-Asa
- Germany · Rosuass
- Spain · Aspifox, Roasax
- Greece · Rosu-Asa, Rosuvastatin + Acetylsalicylic Acid/ Rafarm
- Croatia · Rosix Duo
- Hungary · Xeterduo
- Italy · Asadrox, Lugarexia
- Portugal · Aspifox, Estasp
- Slovenia · Belorostin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0123c6cc-e2b6-4ec2-9e52-774326948e43 GET /v1/drugs/0123c6cc-e2b6-4ec2-9e52-774326948e43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "5 mg + 100 mg",
"packaging": "05909991451578 ¦ Rp ¦ 139782\n28 kaps.\n05909991451585 ¦ Rp ¦ 139783\n30 kaps.\n05909991451592 ¦ Rp ¦ 139784\n56 kaps.\n05909991451608 ¦ Rp ¦ 139785\n90 kaps.",
"substance": "Rosuvastatinum 5 mg + Acidum acetylsalicylicum 100 mg",
"common_name": "Rosuvastatinum + Acidum acetylsalicylicum",
"pl_product_id": "100407900",
"pozwolenie_nr": "26437",
"auth_procedure": "DCP",
"authorisation_validity": "2024-06-25"
}See everything about rosuvastatin und acetylsalicylsäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.